Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines

被引:108
|
作者
Tsuji, S
Kawano, S
Sawaoka, H
Takei, Y
Kobayashi, I
Nagano, K
Fusamoto, H
Kamada, T
机构
[1] First Department of Medicine, Osaka University, School of Medicine, Suita, 565
关键词
D O I
10.1016/S0952-3278(96)90095-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclooxygenase (COX) consists of two isozymes, COX-1 and COX-2. The roles of these isozymes in the gastrointestinal tract are unknown. We investigated messenger RNA expression of the COX-1 and COX-2 genes in the gastrointestinal cancer cell lines MKN28, MKN45, KATO III CACO-2, DLD-1 and LoVo. These cell lines expressed comparable levels of COX-1 mRNA, although their expression of COX-2 varied. Therefore, we studied the effects of NS-398 and indomethacin, specific and non-specific inhibitors for COX-2, on proliferation of the cell lines. Both of the inhibitors suppressed proliferation of the two cell lines that highly expressed COX-2 (MKN45 and CACO-2). However, these inhibitors exerted minimal effects on proliferation of the other cell lines, which expressed significantly lower levels of COX-2. Therefore, it was proposed that COX-2 participates in proliferation of cancer cells because of over expression of the COX-2 gene.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [41] Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines
    Noda, M
    Tatsumi, Y
    Tomizawa, M
    Takama, T
    Mitsufuji, S
    Sugihara, H
    Kashima, K
    Hattori, T
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (11) : 896 - 904
  • [42] Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines
    Masao Noda
    Yoichi Tatsumi
    Muneta Tomizawa
    Takafumi Takama
    Shoji Mitsufuji
    Hiroyuki Sugihara
    Kei Kashima
    Takanori Hattori
    Journal of Gastroenterology, 2002, 37 : 896 - 904
  • [43] The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines
    Park, SW
    Lee, SG
    Song, SH
    Heo, DS
    Park, BJ
    Lee, DW
    Kim, KH
    Sung, MW
    INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) : 729 - 738
  • [44] The effect of nitric oxide on cyclooxygenase-2 expression in cancer and non-cancerous cell lines.
    Park, S
    Ha, J
    Sung, M
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6251S - 6252S
  • [45] GENIPOSIDE INHIBITS GROWTH OF OVARIAN CANCER CELL LINES IN VITRO VIA CYCLOOXYGENASE-2 AND APOPTOTIC PATHWAYS
    Qin, C.
    Liou, Y.
    Wu, N.
    Lv, Q.
    Zhou, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1005 - 1005
  • [46] The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines
    Gilhooly, EM
    Rose, DP
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (02) : 267 - 270
  • [47] Transcriptional regulation of cyclooxygenase-2 promoter activity in gastrointestinal cancer cells.
    Sheehan, KM
    Byrne, MF
    Kenealy, MR
    Fitzgerald, DJ
    Murray, FE
    GASTROENTEROLOGY, 2000, 118 (04) : A56 - A56
  • [48] Involvement of heparanase in cancer development through induction of Cyclooxygenase-2 (COX-2)
    Naomoto, Yoshio, Sr.
    Okawa, Takaomi
    Nobuhisa, Tetsuji
    Imada, Takako
    Ohtawa, Yasuyuki
    Shirakawa, Yasuhiro
    Yamatsuji, Tomoki
    Matsuoka, Junji
    Haisa, Minoru
    Gunduz, Mehmet
    Nakajima, Motowo
    Tanaka, Noriaki
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Involvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory pain
    Martínez, RV
    Reval, MID
    Campos, MD
    Terrón, JA
    Ramírez, AMD
    López-Muñoz, FJ
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (03) : 405 - 412
  • [50] Exogenous microRNA-101 suppresses cell proliferation by downregulation of cyclooxygenase-2 expression in prostate cancer cell line
    Hao, Yubin
    Pang, Xiaowu
    Zhao, Yuan
    Califano, Joseph A.
    Gu, Xinbin
    CANCER RESEARCH, 2010, 70